Animal Hospitals Facing IV and Surgical Scrub Shortages? APHIA: Supply is Stable
Taiwan's APHIA confirmed that medical supplies for animal hospitals, including IV fluids and surgical scrubs, remain stable. They dismissed social media rumors of shortages and planned to discuss expanding the list of human medicines available for veterinary use in May.
📋 Article Processing Timeline
- 📰 Published: April 23, 2026 at 22:07
- 🔍 Collected: April 23, 2026 at 22:31 (24 min after Published)
- 🤖 AI Analyzed: April 23, 2026 at 23:37 (1h 5m after Collected)
Recently, some veterinarians expressed concerns on social media regarding potential shortages of IV fluids and surgical scrubs in animal hospitals. The Animal and Plant Health Inspection Agency (APHIA) stated today that, following an investigation, relevant medical supplies are stable and there are no shortages.
Regarding the concerns about pet medical IV fluids, APHIA released a press release stating that Ringer's solution and most other IV products commonly used in clinical treatment are available as animal-specific products, and the overall supply is stable without any stockouts.
Furthermore, allegations that certain items were removed from the "Categories of Human Medicines for Veterinarians to Treat Dogs, Cats, and Non-Economic Animals" in a recent amendment on April 17 are a misunderstanding. These medicines are supplied as animal drugs and were not affected by the latest regulatory adjustment.
APHIA also noted that external surgical scrubs are not classified as prescription human medicines. If used for hand disinfection by medical personnel, they can be purchased through regular commercial channels.
Addressing the request to include surgical scrubs in the human medicine category for veterinary use, APHIA stated that this will be discussed in an upcoming special assessment committee meeting scheduled for May. Veterinary associations will collect clinical needs from their members and submit applications to APHIA. These will then be reviewed by a panel comprising experts from the FDA, CDC, and the veterinary and pharmacology fields. If approved, they will be included in the permitted list.
APHIA emphasized that animal medicines are specifically designed for animals and are approved after relevant inspections and safety tests. Human medicines are used as supplements when animal-specific drugs are insufficient, based on professional veterinary judgment. This system is designed to ensure uninterrupted animal healthcare while gradually building a stable and safe medication framework.
In the future, APHIA will continue to gather clinical opinions and conduct "rolling reviews" of the human medicine list for animal use, considering increased flexibility. They will also consolidate information on procurement sources to assist veterinary associations in informing their members, facilitating clinical access to medication.
Regarding the concerns about pet medical IV fluids, APHIA released a press release stating that Ringer's solution and most other IV products commonly used in clinical treatment are available as animal-specific products, and the overall supply is stable without any stockouts.
Furthermore, allegations that certain items were removed from the "Categories of Human Medicines for Veterinarians to Treat Dogs, Cats, and Non-Economic Animals" in a recent amendment on April 17 are a misunderstanding. These medicines are supplied as animal drugs and were not affected by the latest regulatory adjustment.
APHIA also noted that external surgical scrubs are not classified as prescription human medicines. If used for hand disinfection by medical personnel, they can be purchased through regular commercial channels.
Addressing the request to include surgical scrubs in the human medicine category for veterinary use, APHIA stated that this will be discussed in an upcoming special assessment committee meeting scheduled for May. Veterinary associations will collect clinical needs from their members and submit applications to APHIA. These will then be reviewed by a panel comprising experts from the FDA, CDC, and the veterinary and pharmacology fields. If approved, they will be included in the permitted list.
APHIA emphasized that animal medicines are specifically designed for animals and are approved after relevant inspections and safety tests. Human medicines are used as supplements when animal-specific drugs are insufficient, based on professional veterinary judgment. This system is designed to ensure uninterrupted animal healthcare while gradually building a stable and safe medication framework.
In the future, APHIA will continue to gather clinical opinions and conduct "rolling reviews" of the human medicine list for animal use, considering increased flexibility. They will also consolidate information on procurement sources to assist veterinary associations in informing their members, facilitating clinical access to medication.